Search
China's Innovative Drug Pipeline: Accounting for Approximately 30% of Global Research
2025-08-22 /
Read about 0 minute
Author：小编
Throughout the 14th Five-Year Plan period, China has significantly enhanced drug safety oversight, fostered the high-quality growth of its pharmaceutical industry, and prioritized meeting the medication demands of its populace. Today, China's pharmaceutical industry stands as the second largest globally, with its innovative drug pipeline comprising approximately 30% of the worldwide total. Since the inception of the 14th Five-Year Plan, 387 pediatric medications and 147 rare disease drugs have been greenlit for market access, thereby effectively addressing the medication needs of key demographic groups.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
